We recently had the privilege of interviewing Mohamed ElKamshoushy, Senior Business Consultant in the Healthcare sector of the MENA region. With over 25 years of experience in the pharmaceutical industry, he has held pivotal roles at several organizations worldwide. With a strong track record of success, Mohamed ElKamshoushy offers innovative solutions and strategic guidance in the dynamic business landscape of the MENA region.
The Beginning
We started the interview by asking, “Could you start by telling us about your professional journey and inspiration behind jumping into this industry?”
Mohamed shared, “My journey began on the clinical side, as a Pharmacist. I was fascinated by the science of new medicines. After I started my professional career in pharmaceutical companies, I kept seeing a gap: groundbreaking therapies would arrive, but the healthcare ecosystem—doctors, payers, and patients—was often slow to understand and adopt them. That gap between innovation and access is what inspired my jump into the commercial side.
I moved into marketing and commercials, learning how to translate complex data for clinicians. From there, I progressed into brand management, market access, and eventually leadership roles overseeing entire portfolios. The core inspiration has remained constant: to ensure that every patient who needs a transformative medicine can get it. That requires not just great science, but brilliant strategy, communication, and execution—the heart of pharmaceutical marketing.”
Lessons Learnt in the Process
To learn more about the experiences that shaped Mohamed ElKamshoushy’s journey, we asked, “As a professional in this field, what are a few lessons that helped you in leading your team and business?”
He shared, “Three lessons stand out in my journey — the ‘three-legged stool’ is non-negotiable. Every decision must balance Clinical Value (the data), Commercial Viability (the strategy), and Compliance (the guardrails). Ignore one, and the stool collapses; this framework creates disciplined, sustainable growth.
Moreover, success is defined by stakeholders, not just sales. You must map and understand the unique needs of each stakeholder: the Physician (efficacy/safety), the Payer (cost/outcomes), the Patient (quality of life), and the Regulator (evidence). Winning requires tailored value propositions for each.
And lastly, agility beats perfection in a dynamic landscape. The market access environment, competitor actions, and digital channels change rapidly. So, empower your teams with clear objectives and guardrails, then encourage agile testing, learning, and adapting. A ‘perfect’ plan launched too late is a failure.”
Navigating through Challenges
Every professional faces inevitable challenges in their journey. We asked, “Would you like to share what you feel is a major challenge in starting a business or career? And how did you overcome it?”
He mentioned, “The single greatest challenge is navigating extreme complexity with constrained resources. Unlike many industries, you are not just selling to a ‘customer’ — you are launching into a labyrinth of stakeholders, each with veto power, against a backdrop of intense regulation and long, costly development cycles.
The way I overcame this was through strategic prioritization and ecosystem mapping. Before building a massive plan, I would identify the single most critical barrier to adoption, build a minimal viable commercial model to address that barrier first, and secure early, tangible wins with a focused resource deployment to build credibility and secure further investment. It’s about proving the path to ROI in a measured, evidence-based way.”
Plans we asked Mohamed ElKamshoushy
We further asked, “What are your plans with the services/products that you provide? Could you share a bit about it with our viewers?”
“Our core focus is on ‘Launch Excellence as a Service’ for specialty and orphan drugs. We see a trend where brilliant biotechs have incredible science but lack the integrated commercial engine to navigate their first launch. Our product is a modular platform covering:
- Pre-launch ‘War-Gaming’: Simulating pricing, reimbursement, and competitive scenarios.
- Integrated Stakeholder Blueprints: Mapping the journey for HCPs and payers with synchronized medical and commercial touchpoints.
- Digital-First Patient Support Programs that improve adherence and generate real-world evidence.
The plan is to move from a service model to a technology-enabled partner, using our proprietary data analytics to de-risk launch decisions for our clients,” Mohamed shared.
Reshaping Businesses with AI
Nowadays, as you would see, AI is everywhere. Even businesses are adapting to it increasingly. We asked Mohamed ElKamshoushy, “What are your thoughts on this?”
He reflected, “AI is not just a trend; it’s the most powerful force reshaping our industry since the biotech revolution. My view is pragmatic and strategic. On the commercial side, AI is transformative for hyper-personalization. It analyzes HCP prescribing patterns, publication interests, and digital behavior to allow for one-to-one engagement at scale, ensuring the right message reaches the right stakeholder at the right time.
While on the market access side, AI can model pricing and reimbursement outcomes across different geographies, predict payer objections, and help craft dynamic value dossiers.
And lastly, in pharma, AI must be the engine, not the driver. All outputs must be governed by medical, legal, and regulatory review. The human-in-the-loop is non-negotiable for accuracy, compliance, and ethical engagement. Our strategy is to embed AI in our insights generation and operational efficiency, freeing our teams to do higher-level strategic thinking and relationship building.”
Words of Wisdom for Beginners
Lastly, we asked, “What would be your advice to beginners in this field or in any field of business?”
Mohamed shared, “First, cultivate ‘T-Shaped’ expertise; develop a great vertical skill, but also a broad understanding of the entire pharmaceutical value chain—from R&D through to patient support. This allows you to connect the dots and see the bigger picture.
Second, become bilingual in both science and business. You must be able to critically appraise a clinical paper and a profit & loss statement with equal comfort. Credibility in this industry is built on this dual fluency.
Finally, build resilience and a long-term perspective. This is a marathon, not a sprint. Setbacks in clinical trials, regulatory delays, and failed launches are part of the landscape. The most successful professionals are those who learn from these experiences, adapt their strategies, and remain driven by the ultimate goal: improving patient lives.”
Connect with Mohamed ElKamshoushy on LinkedIn to gain industry insights.
Also Read:-
Ruth Burk Interview: Women’s Leadership, AI Impact & Sustainable Growth
Katie Burnell On Redefining UAE Real Estate With Innovation & AI
About Author
